Insider Trading Alert - AKAM, JBLU, MSCC, GBX And MDSO Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Nov. 14, 2013, 154 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $292.50 to $467,462,888.00.

Highlighted Stocks Traded by Insiders:

Akamai Technologies (AKAM) - FREE Research Report

Coyne Martin M Ii who is Director at Akamai Technologies sold 2,500 shares at $45.50 on Nov. 14, 2013. Following this transaction, the Director owned 21,761 shares meaning that the stake was reduced by 10.3% with the 2,500 share transaction.

The shares most recently traded at $46.53, up $1.03, or 2.21% since the insider transaction. Historical insider transactions for Akamai Technologies go as follows:

  • 4-Week # shares sold: 14,897
  • 12-Week # shares sold: 24,580
  • 24-Week # shares sold: 35,922

The average volume for Akamai Technologies has been 2.1 million shares per day over the past 30 days. Akamai Technologies has a market cap of $8.1 billion and is part of the technology sector and internet industry. Shares are up 10.58% year to date as of the close of trading on Tuesday.

Akamai Technologies, Inc. provides content delivery and cloud infrastructure services for accelerating and improving the delivery of content and applications over the Internet in the United States and internationally. The company has a P/E ratio of 29.4. Currently there are 12 analysts that rate Akamai Technologies a buy, no analysts rate it a sell, and 8 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on AKAM - FREE

TheStreet Quant Ratings rates Akamai Technologies as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, impressive record of earnings per share growth, compelling growth in net income and reasonable valuation levels. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full Akamai Technologies Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

JetBlue Airways Corporation (JBLU) - FREE Research Report

Hnat James G who is EVP & General Counsel at JetBlue Airways Corporation sold 8,000 shares at $8.50 on Nov. 14, 2013. Following this transaction, the EVP & General Counsel owned 17,487 shares meaning that the stake was reduced by 31.39% with the 8,000 share transaction.

Maruster Robert Alan who is EVP-Chief Operating Officer at JetBlue Airways Corporation sold 36,417 shares at $8.75 on Nov. 14, 2013. Following this transaction, the EVP-Chief Operating Officer owned 29,378 shares meaning that the stake was reduced by 55.35% with the 36,417 share transaction.

The shares most recently traded at $8.68, down $0.07, or 0.82% since the insider transaction. Historical insider transactions for JetBlue Airways Corporation go as follows:

  • 4-Week # shares sold: 8,500
  • 12-Week # shares sold: 8,500
  • 24-Week # shares sold: 8,500

The average volume for JetBlue Airways Corporation has been 4.4 million shares per day over the past 30 days. Shares are up 34.44% year to date as of the close of trading on Tuesday.

JetBlue Airways Corporation, a passenger airline company, provides air transportation services. The company has a P/E ratio of 19.7. Currently there is 1 analyst that rates JetBlue Airways Corporation a buy, 2 analysts rate it a sell, and 6 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on JBLU - FREE

TheStreet Quant Ratings rates JetBlue Airways Corporation as a buy. The company's strengths can be seen in multiple areas, such as its growth in earnings per share, revenue growth, good cash flow from operations, solid stock price performance and increase in net income. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full JetBlue Airways Corporation Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Microsemi (MSCC) - FREE Research Report

Brandi Ralph who is Executive Vice President at Microsemi sold 14,667 shares at $23.27 on Nov. 14, 2013. Following this transaction, the Executive Vice President owned 62,833 shares meaning that the stake was reduced by 18.93% with the 14,667 share transaction.

Peterson James J who is Chairman of the Board & CEO at Microsemi sold 39,667 shares at $23.27 on Nov. 14, 2013. Following this transaction, the Chairman of the Board & CEO owned 307,651 shares meaning that the stake was reduced by 11.42% with the 39,667 share transaction.

Hohener John W who is EVP & Chief Financial Officer at Microsemi sold 15,500 shares at $23.27 on Nov. 14, 2013. Following this transaction, the EVP & Chief Financial Officer owned 89,620 shares meaning that the stake was reduced by 14.75% with the 15,500 share transaction.

Litchfield Steven G who is EVP & Chief Strategy Officer at Microsemi sold 15,833 shares at $23.28 on Nov. 14, 2013. Following this transaction, the EVP & Chief Strategy Officer owned 87,242 shares meaning that the stake was reduced by 15.36% with the 15,833 share transaction.

Goren David who is SVP Bus Affairs, Compl, Legal at Microsemi sold 9,667 shares at $23.27 on Nov. 14, 2013. Following this transaction, the SVP Bus Affairs, Compl, Legal owned 58,383 shares meaning that the stake was reduced by 14.21% with the 9,667 share transaction.

The shares most recently traded at $23.34, up $0.07, or 0.3% since the insider transaction. Historical insider transactions for Microsemi go as follows:

  • 4-Week # shares sold: 33,334
  • 12-Week # shares sold: 297,601
  • 24-Week # shares sold: 329,601

The average volume for Microsemi has been 494,300 shares per day over the past 30 days. Microsemi has a market cap of $2.2 billion and is part of the technology sector and electronics industry. Shares are up 10.46% year to date as of the close of trading on Tuesday.

Microsemi Corporation engages in the design, manufacture, and marketing of analog and mixed-signal integrated circuits (ICs) primarily in the United States, Europe, and Asia. The company has a P/E ratio of 11.9. Currently there are 4 analysts that rate Microsemi a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on MSCC - FREE

TheStreet Quant Ratings rates Microsemi as a buy. The company's strengths can be seen in multiple areas, such as its impressive record of earnings per share growth, compelling growth in net income, largely solid financial position with reasonable debt levels by most measures, solid stock price performance and expanding profit margins. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. Get the full Microsemi Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Greenbrier Companies (GBX) - FREE Research Report

Malik Maren C. who is Vice President Admin at Greenbrier Companies sold 1,255 shares at $31.77 on Nov. 14, 2013. Following this transaction, the Vice President Admin owned 12,675 shares meaning that the stake was reduced by 9.01% with the 1,255 share transaction.

The shares most recently traded at $32.18, up $0.41, or 1.29% since the insider transaction. Historical insider transactions for Greenbrier Companies go as follows:

  • 4-Week # shares sold: 35,432
  • 12-Week # shares sold: 35,867
  • 24-Week # shares sold: 35,867

The average volume for Greenbrier Companies has been 284,700 shares per day over the past 30 days. Greenbrier Companies has a market cap of $873.9 million and is part of the services sector and transportation industry. Shares are up 93.07% year to date as of the close of trading on Tuesday.

The Greenbrier Companies, Inc. designs, manufactures, and markets railroad freight car equipment in North America and Europe. The stock currently has a dividend yield of 3.44%. Currently there are 9 analysts that rate Greenbrier Companies a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on GBX - FREE

TheStreet Quant Ratings rates Greenbrier Companies as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance and increase in net income. However, as a counter to these strengths, we also find weaknesses including disappointing return on equity and poor profit margins. Get the full Greenbrier Companies Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Medidata Solutions (MDSO) - FREE Research Report

De Vries Glen Michael who is President at Medidata Solutions sold 10,000 shares at $110.33 on Nov. 14, 2013. Following this transaction, the President owned 575,748 shares meaning that the stake was reduced by 1.71% with the 10,000 share transaction.

The shares most recently traded at $113.05, up $2.72, or 2.41% since the insider transaction. Historical insider transactions for Medidata Solutions go as follows:

  • 4-Week # shares sold: 45,871
  • 12-Week # shares sold: 45,871
  • 24-Week # shares sold: 113,093

The average volume for Medidata Solutions has been 239,400 shares per day over the past 30 days. Shares are up 182.49% year to date as of the close of trading on Tuesday.

Medidata Solutions, Inc. provides cloud-based clinical development solutions for life sciences organizations in the United States and internationally. The company has a P/E ratio of 128.7. Currently there are 4 analysts that rate Medidata Solutions a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on MDSO - FREE

TheStreet Quant Ratings rates Medidata Solutions as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, increase in net income, good cash flow from operations, expanding profit margins and solid stock price performance. We feel these strengths outweigh the fact that the company is trading at a premium valuation based on our review of its current price compared to such things as earnings and book value. Get the full Medidata Solutions Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Data for this article provided by Zacks Investment Research

null

More from Markets

Facebook, Boeing, Shire and Credit Suisse - 5 Things You Must Know

Facebook, Boeing, Shire and Credit Suisse - 5 Things You Must Know

Facebook Prepares for Earnings and 4 Other Stories You Must Know Wednesday

Facebook Prepares for Earnings and 4 Other Stories You Must Know Wednesday

Facebook's Investors Have a Big Day Ahead

Facebook's Investors Have a Big Day Ahead

The Global Stock Market Rout Spreads Across the World

The Global Stock Market Rout Spreads Across the World

Comcast Details $30 Billion Bid for Britain's Sky in Takeover Battle With Fox

Comcast Details $30 Billion Bid for Britain's Sky in Takeover Battle With Fox